Nexalin technology appoints highly experienced financial leader justin van fleet as cfo to support nexalin's next phase of growth and strategic initiatives

Houston, tx, aug. 01, 2025 (globe newswire) -- nexalin technology, inc. (nasdaq: nxl; nxliw) (the “company” or “nexalin”), the leader in deep intracranial frequency stimulation (difs™) of the brain, today announced the appointment of justin van fleet, cpa, as chief financial officer, effective august 1, 2025.
NXL Ratings Summary
NXL Quant Ranking